Intech Investment Management LLC Fulcrum Therapeutics, Inc. Transaction History
Intech Investment Management LLC
- $10 Billion
- Q4 2024
A detailed history of Intech Investment Management LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 30,499 shares of FULC stock, worth $112,541. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,499
Previous 17,442
74.86%
Holding current value
$112,541
Previous $62,000
130.65%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding FULC
# of Institutions
134Shares Held
52.8MCall Options Held
3.08MPut Options Held
316K-
Ra Capital Management, L.P. Boston, MA10.2MShares$37.7 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$19.4 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$17.6 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$12.3 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $192M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...